Legal
Version February 26, 2026
This page outlines the trading risk notice, licensing references, regulatory collaborators, and brand information provided for OramaX365 and the related entities referenced below.
Trading Contracts for Difference (CFDs) involves significant risk and may not be suitable for all investors. Approximately 68% of retail investor accounts lose money when trading CFDs.
Clients must review and understand these risks before engaging in trading activities, as CFDs carry a high risk of losing money.
OramaX365 is a strategy provider regulated by the Czech National Bank (CNB) under license number 19819145.
For more information, visit wealthwaveaffiliation.com/legal.
The Strategy Provider OramaX365 provides only general advice, investment research, and trading signals of a general nature in collaboration with:
The copy trading activities offered by the Strategy Provider OramaX365 are managed by Wealth Wave Affiliation Ltd. in collaboration with Mordex Asset Management, in compliance with regulations governing copy trading and mirror trading services.
This includes adherence to ESMA Q&A 2012/382, Question 9: Article 4(1)(9) of MiFID - Automatic Execution of Trading Signals.
Investors are advised to independently evaluate their financial situation and consider whether they can bear the risk of losing their investments before engaging in trading or copy trading activities.
If you have any questions regarding the license, please email compliance@wealthwaveaffiliation.com.
The brand Oramax365. is a part of Wealth Wave Affiliation Ltd.
Wolfy OÜ operates under the business name "Oramax365." References to "Oramax365" in this document are references to Wolfy OÜ.